- What's Tisch?
- Stem Cell Trial
- Get Involved
Neurology Live: Intrathecal Mesenchymal Stem Cells are Potential Treatment for Progressive Multiple Sclerosis: Saud A. Sadiq, MD, FAAN
MS News Today: AAN 2023: MSC-NP aids walking in advanced progressive MS patients
BioInformant: FDA-Approved Phase II Stem Cell Treatment Trial Shows Significant and Diverse Improvements for Multiple Sclerosis (MS) Patients
New Scientist: Stem cell therapy reduces symptoms of progressive MS for some people
Neuro Rehab Times: New hope for potential MS treatment
Neuro Rehab Times: 'Mini brains' shed new light on MS
RegMedNet: Microglia may be a therapeutic target of mesenchymal stem cell-derived neural progenitor therapy.
MS News Today: Stem cell therapy MSC-NP can ease inflammatory activity in brain cells
Managed Healthcare Executive: Researchers Develop 'Mini-Brain' Model That Could Help Identify Targets for MS Treatment
National MS Society:New Study Shows How Primary Progressive MS May Differ from Other Forms of MS
‘Mini-brain’ models point to poorer oligodendrocyte growth in PPMS
Primary Progressive MS confirmed as own disorder in mouse study
Primary progressive multiple sclerosis is a distinct disease (fiercebiotech.com)
BioSpace: Highlighted by Amylyx, the ALS Space is Gaining Momentum
Managed Healthcare Executive:COVID-19 Vaccination and People with MS: T Cells Boosted, Antibdies Not So Much.
ALS News Today: Cholesterol Transporter May Be Stronger Trigger of Sporadic ALS
RealTalk MS Podcast: Interview with Tisch MSRCNY Scientist, Dr. Roberto Alfonso
Mice injected with spinal fluid from ALS patients offer potential therapeutic target
When spinal fluid from ALS patients was put into mice, the mice got weak. An unlikely protein could be the culprit
Brain Communications: Apolipoprotein B-100-mediated motor neuron degeneration in sporadic amyotrophic lateral sclerosis
MS News Today: Anti-CD20 Therapies Help Mount T-cell Response to COVID-19 Vaccines
Frontiers in Immunology: Strong T-cell activation in response to CVOID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies
Stem Cells Treatments Show Promise in MS (managedhealthcareexecutive.com)
RealTalk MS Podcast: Episode 250 featuring Dr. Saud Sadiq
Biospace: Research Shows Stem Cells Might Become a Game Changer for Multiple Sclerosis
The Joan Hamburg Show Director and Chief Research Scientist of the Tisch MS Research Center of New York, Dr. Saud A. Sadiq, talks with Joan Hamburg about MS and our Phase II stem cell trial.
NY Mag: Dr. Sadiq-Damage Control
521 West 57th Street
New York, NY 10019
Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.